|
Volumn 98, Issue 26, 2001, Pages 15173-15178
|
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MYELIN;
MYELIN ASSOCIATED GLYCOPROTEIN;
PEPTIDE;
PEPTIDE P472;
PROTEIN NOGO A;
UNCLASSIFIED DRUG;
ACTIVE IMMUNIZATION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
AUTOIMMUNITY;
CELLULAR IMMUNITY;
CENTRAL NERVOUS SYSTEM FUNCTION;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG SAFETY;
FEMALE;
LYMPHOCYTOPOIESIS;
MALE;
NERVE CELL DEGENERATION;
NERVE FIBER REGENERATION;
NEUROPROTECTION;
NONHUMAN;
PASSIVE IMMUNIZATION;
PRIORITY JOURNAL;
RAT;
SPINAL CORD INJURY;
T LYMPHOCYTE;
VACCINATION;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIGENS;
MOLECULAR SEQUENCE DATA;
MYELIN PROTEINS;
MYELIN SHEATH;
PEPTIDE FRAGMENTS;
RATS;
RATS, INBRED LEW;
RATS, SPRAGUE-DAWLEY;
SPINAL CORD;
SPINAL CORD INJURIES;
T-LYMPHOCYTES;
VACCINES;
ANIMALIA;
|
EID: 0035910038
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.011585298 Document Type: Article |
Times cited : (93)
|
References (39)
|